Table IV.
Clinically relevant outcome achievement at final follow-upa
|
Negative response
(N = 22) |
Positive response
(N = 74) |
P-value b | |
|---|---|---|---|
| mHHS | |||
| MCID (Δ8) | 77.3% (17) | 89.2% (66) | 0.152 |
| PASS (74) | 77.3% (17) | 78.4% (58) | 0.912 |
| HOS-ADLs | |||
| MCID (Δ5) | 72.7% (16) | 91.9% (68) | 0.017 |
| PASS (87) | 68.2% (15) | 79.7% (59) | 0.258 |
| HOS-sports | |||
| MCID (Δ6) | 68.2% (15) | 89.2% (66) | 0.017 |
| PASS (75) | 54.6% (12) | 79.7% (59) | 0.018 |
| VAS Pain Score | |||
| MCID (Δ14.8) | 68.2% (15) | 74.3% (55) | 0.569 |
| PROMIS PI | |||
| MCID (Δ10.9) | 27.3% (6) | 52.7% (39) | 0.036 |
| PROMIS PF | |||
| MCID (Δ5.1) | 59.1% (13) | 77.0% (57) | 0.096 |
MCID = minimum clinically important difference; PASS = patient acceptable symptom state; ADLs = activities of daily living; VAS = Visual Analog Scale; PROMIS = Patient-Reported Outcomes Measurement Information System; HOS = hip outcome score; PI = pain interference; PF = physical function.
Δ = difference between final follow-up score and preoperative score.
a
Boldface indicates statistical significance.
b
P-value was calculated for each category using chi-squared analysis.